Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production

MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed

MSF responds to European Commission’s proposal to revise EU’s pharma legislation

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

Gavi and donors must expand vaccine supply to catch up children up to age five

Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug

MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend monopoly on lifesaving TB drug

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB